PROFOUND MEDICAL CORP. Operating Lease Liability
PROFOUND MEDICAL CORP. (PROF) had Operating Lease Liability of $2.87 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $2.87M.
- 2026-03-31: Operating Lease, Liability $2.96M.
- 2025-12-31: Operating Lease, Liability $213.00K.
- 2024-12-31: Operating Lease, Liability $460.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $2.87M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.96M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $213.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $460.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |